Authors: Goyal Y; Department of Cell and Developmental Biology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA. yogesh.goyal@northwestern.edu.; Center for Synthetic Biology, Northwestern University, Chicago, IL, USA. yogesh.goyal@northwestern.edu.; Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, IL, USA. yogesh.goyal@northwestern.edu.; Department of Bioengineering, School of Engineering and Applied Sciences, University of Pennsylvania, Philadelphia, PA, USA. yogesh.goyal@northwestern.edu., Busch GT; Department of Bioengineering, School of Engineering and Applied Sciences, University of Pennsylvania, Philadelphia, PA, USA., Pillai M; Department of Cell and Developmental Biology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.; Center for Synthetic Biology, Northwestern University, Chicago, IL, USA.; Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, IL, USA., Li J; Genetics and Epigenetics, Cell and Molecular Biology Graduate Group, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Boe RH; Genetics and Epigenetics, Cell and Molecular Biology Graduate Group, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Grody EI; Department of Cell and Developmental Biology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.; Center for Synthetic Biology, Northwestern University, Chicago, IL, USA.; Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, IL, USA., Chelvanambi M; Department of Genomic Medicine, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Dardani IP; Department of Bioengineering, School of Engineering and Applied Sciences, University of Pennsylvania, Philadelphia, PA, USA., Emert B; Genomics and Computational Biology Graduate Group, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Bodkin N; Department of Cell and Developmental Biology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.; Center for Synthetic Biology, Northwestern University, Chicago, IL, USA.; Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, IL, USA., Braun J; Department of Cell and Developmental Biology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.; Center for Synthetic Biology, Northwestern University, Chicago, IL, USA.; Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, IL, USA., Fingerman D; The Wistar Institute, Philadelphia, PA, USA., Kaur A; Department of Bioengineering, School of Engineering and Applied Sciences, University of Pennsylvania, Philadelphia, PA, USA., Jain N; Genetics and Epigenetics, Cell and Molecular Biology Graduate Group, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Ravindran PT; Genetics and Epigenetics, Cell and Molecular Biology Graduate Group, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Mellis IA; Department of Bioengineering, School of Engineering and Applied Sciences, University of Pennsylvania, Philadelphia, PA, USA.; Genomics and Computational Biology Graduate Group, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Kiani K; Genetics and Epigenetics, Cell and Molecular Biology Graduate Group, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Alicea GM; Department of Biochemistry and Molecular Biology, Johns Hopkins School of Public Health, Baltimore, MD, USA.; Department of Oncology, Sidney Kimmel Cancer Center, Johns Hopkins School of Medicine, Baltimore, MD, USA., Fane ME; Department of Biochemistry and Molecular Biology, Johns Hopkins School of Public Health, Baltimore, MD, USA.; Department of Oncology, Sidney Kimmel Cancer Center, Johns Hopkins School of Medicine, Baltimore, MD, USA., Ahmed SS; Department of Cell and Developmental Biology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.; Center for Synthetic Biology, Northwestern University, Chicago, IL, USA.; Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, IL, USA., Li H; The Wistar Institute, Philadelphia, PA, USA., Chen Y; The Wistar Institute, Philadelphia, PA, USA., Chai C; Department of Cell and Developmental Biology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.; Center for Synthetic Biology, Northwestern University, Chicago, IL, USA.; Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.; Center for Reproductive Science, Northwestern University, Chicago, IL, USA., Kaster J; The Wistar Institute, Philadelphia, PA, USA., Witt RG; Department of Genomic Medicine, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Lazcano R; Department of Genomic Medicine, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Ingram DR; Department of Genomic Medicine, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Johnson SB; Department of Genomic Medicine, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Wani K; Department of Genomic Medicine, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Dunagin MC; Department of Bioengineering, School of Engineering and Applied Sciences, University of Pennsylvania, Philadelphia, PA, USA.; Department of Genetics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Lazar AJ; Department of Genomic Medicine, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Weeraratna AT; Department of Biochemistry and Molecular Biology, Johns Hopkins School of Public Health, Baltimore, MD, USA.; Department of Oncology, Sidney Kimmel Cancer Center, Johns Hopkins School of Medicine, Baltimore, MD, USA., Wargo JA; Department of Genomic Medicine, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Herlyn M; The Wistar Institute, Philadelphia, PA, USA., Raj A; Department of Bioengineering, School of Engineering and Applied Sciences, University of Pennsylvania, Philadelphia, PA, USA. arjunrajlab@gmail.com.; Department of Genetics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. arjunrajlab@gmail.com.

Source: Nature [Nature] 2023 Aug; Vol. 620 (7974), pp. 651-659. Date of Electronic Publication: 2023 Jul 19.

Publication Type: Journal Article

Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 0410462 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-4687 (Electronic) Linking ISSN: 00280836 NLM ISO Abbreviation: Nature Subsets: MEDLINE

MeSH Terms: Clone Cells*/drug effects , Clone Cells*/metabolism , Clone Cells*/pathology , Drug Resistance, Neoplasm*/drug effects , Drug Resistance, Neoplasm*/genetics , Neoplasms*/drug therapy , Neoplasms*/genetics , Neoplasms*/pathology , Antineoplastic Agents*/pharmacology, Humans ; DNA Barcoding, Taxonomic ; RNA-Seq ; Single-Cell Gene Expression Analysis ; Tumor Cells, Cultured

Authors: Nishimura T; Department of Pathology and Tumour Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.; Department of Next-generation Clinical Genomic Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.; Department of Breast Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan., Kakiuchi N; Department of Pathology and Tumour Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.; The Hakubi Center for Advanced Research, Kyoto University, Kyoto, Japan.; Department of Gastroenterology and Hepatology, Graduate School of Medicine, Kyoto University, Kyoto, Japan., Yoshida K; Department of Pathology and Tumour Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.; Division of Cancer Evolution, National Cancer Center Research Institute, Tokyo, Japan., Sakurai T; Department of Diagnostic Pathology, Kyoto University Hospital, Kyoto, Japan.; Department of Diagnostic Pathology, Osaka Red Cross Hospital, Osaka, Japan., Kataoka TR; Department of Diagnostic Pathology, Kyoto University Hospital, Kyoto, Japan.; Department of Pathology, Iwate Medical University, Iwate, Japan., Kondoh E; Department of Gynecology and Obstetrics, Graduate School of Medicine, Kyoto University, Kyoto, Japan.; Department of Obstetrics and Gynecology Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan., Chigusa Y; Department of Gynecology and Obstetrics, Graduate School of Medicine, Kyoto University, Kyoto, Japan., Kawai M; Department of Pediatrics, Graduate School of Medicine, Kyoto University, Kyoto, Japan., Sawada M; Adachi Hospital, Kyoto, Japan., Inoue T; Adachi Hospital, Kyoto, Japan., Takeuchi Y; Department of Pathology and Tumour Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.; Department of Diagnostic Pathology, Kyoto University Hospital, Kyoto, Japan., Maeda H; Department of Pathology and Tumour Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.; Department of Diagnostic Pathology, Kyoto University Hospital, Kyoto, Japan., Baba S; Pathology Project for Molecular Targets, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan.; Division of Pathology, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan.; Department of Pathology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan., Shiozawa Y; Department of Pathology and Tumour Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan., Saiki R; Department of Pathology and Tumour Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan., Nakagawa MM; Department of Pathology and Tumour Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.; Department of Next-generation Clinical Genomic Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan., Nannya Y; Department of Pathology and Tumour Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.; Division of Hematopoietic Disease Control, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan., Ochi Y; Department of Pathology and Tumour Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan., Hirano T; Department of Pathology and Tumour Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.; Department of Gastroenterology and Hepatology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.; Institute for the Advanced Study of Human Biology (WPI-ASHBi), Kyoto University, Kyoto, Japan., Nakagawa T; Department of Pathology and Tumour Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.; Institute for the Advanced Study of Human Biology (WPI-ASHBi), Kyoto University, Kyoto, Japan., Inagaki-Kawata Y; Department of Pathology and Tumour Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.; Department of Breast Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan., Aoki K; Department of Pathology and Tumour Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan., Hirata M; Department of Diagnostic Pathology, Kyoto University Hospital, Kyoto, Japan., Nanki K; Department of Organoid Medicine, Sakaguchi Laboratory, Keio University School of Medicine, Tokyo, Japan., Matano M; Department of Organoid Medicine, Sakaguchi Laboratory, Keio University School of Medicine, Tokyo, Japan., Saito M; Department of Organoid Medicine, Sakaguchi Laboratory, Keio University School of Medicine, Tokyo, Japan.; Osaka Research Center for Drug Discovery, Otsuka Pharmaceutical Company, Limited, Osaka, Japan., Suzuki E; Department of Breast Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan.; Breast Surgery Department, Kobe City Medical Center General Hospital, Hyogo, Japan., Takada M; Department of Breast Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan., Kawashima M; Department of Breast Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan., Kawaguchi K; Department of Breast Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan., Chiba K; Division of Genome Analysis Platform Development, National Cancer Center Research Institute, Tokyo, Japan., Shiraishi Y; Division of Genome Analysis Platform Development, National Cancer Center Research Institute, Tokyo, Japan., Takita J; Department of Pediatrics, Graduate School of Medicine, Kyoto University, Kyoto, Japan., Miyano S; Department of Integrated Analytics, M&D Data Science Center, Tokyo Medical and Dental University, Tokyo, Japan.; Human Genome Center, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan., Mandai M; Department of Gynecology and Obstetrics, Graduate School of Medicine, Kyoto University, Kyoto, Japan., Sato T; Department of Organoid Medicine, Sakaguchi Laboratory, Keio University School of Medicine, Tokyo, Japan., Takeuchi K; Pathology Project for Molecular Targets, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan.; Division of Pathology, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan.; Department of Pathology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan., Haga H; Department of Diagnostic Pathology, Kyoto University Hospital, Kyoto, Japan., Toi M; Department of Breast Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan., Ogawa S; Department of Pathology and Tumour Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan. sogawa-tky@umin.ac.jp.; Institute for the Advanced Study of Human Biology (WPI-ASHBi), Kyoto University, Kyoto, Japan. sogawa-tky@umin.ac.jp.; Department of Medicine, Centre for Haematology and Regenerative Medicine, Karolinska Institute, Stockholm, Sweden. sogawa-tky@umin.ac.jp.

Source: Nature [Nature] 2023 Aug; Vol. 620 (7974), pp. 607-614. Date of Electronic Publication: 2023 Jul 26.

Publication Type: Journal Article

Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 0410462 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-4687 (Electronic) Linking ISSN: 00280836 NLM ISO Abbreviation: Nature Subsets: MEDLINE

MeSH Terms: Breast Neoplasms*/diagnosis , Breast Neoplasms*/genetics , Breast Neoplasms*/pathology , Cell Lineage*/genetics , Clone Cells*/metabolism , Clone Cells*/pathology , Evolution, Molecular* , Mutagenesis* , Mutation*, Adolescent ; Adult ; Female ; Humans ; Young Adult ; Epigenesis, Genetic ; Epithelial Cells/cytology ; Epithelial Cells/metabolism ; Epithelium/pathology ; Microdissection ; Mutation Rate ; Premenopause ; Tumor Microenvironment

Authors: Guo R; State Key Laboratory of Drug Research, National Center for Drug Screening, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China., Jiang M; State Key Laboratory of Drug Research, National Center for Drug Screening, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China.; School of Life Science and Technology, ShanghaiTech University, Shanghai, 201210, China.; University of Chinese Academy of Sciences, No.19 A Yuquan Road, 100049, Beijing, China., Wang G; Department of Pharmaceutics, School of Pharmacy, Fudan University, Shanghai, 201203, China., Li B; State Key Laboratory of Drug Research, National Center for Drug Screening, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China.; University of Chinese Academy of Sciences, No.19 A Yuquan Road, 100049, Beijing, China.; School of Pharmaceutical Science and Technology, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, Hangzhou, 310024, China., Jia X; State Key Laboratory of Drug Research, National Center for Drug Screening, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China.; University of Chinese Academy of Sciences, No.19 A Yuquan Road, 100049, Beijing, China., Ai Y; State Key Laboratory of Drug Research, National Center for Drug Screening, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China.; University of Chinese Academy of Sciences, No.19 A Yuquan Road, 100049, Beijing, China.; School of Pharmaceutical Science and Technology, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, Hangzhou, 310024, China., Chen S; State Key Laboratory of Drug Research, National Center for Drug Screening, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China.; University of Chinese Academy of Sciences, No.19 A Yuquan Road, 100049, Beijing, China., Tang P; State Key Laboratory of Drug Research, National Center for Drug Screening, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China.; School of Pharmaceutical Science, Nanchang University, Nanchang, 330006, China., Liu A; State Key Laboratory of Drug Research, National Center for Drug Screening, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China., Yuan Q; State Key Laboratory of Drug Research, National Center for Drug Screening, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China., Xie X; State Key Laboratory of Drug Research, National Center for Drug Screening, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China. xxie@simm.ac.cn.; School of Life Science and Technology, ShanghaiTech University, Shanghai, 201210, China. xxie@simm.ac.cn.; University of Chinese Academy of Sciences, No.19 A Yuquan Road, 100049, Beijing, China. xxie@simm.ac.cn.; Department of Pharmaceutics, School of Pharmacy, Fudan University, Shanghai, 201203, China. xxie@simm.ac.cn.; School of Pharmaceutical Science and Technology, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, Hangzhou, 310024, China. xxie@simm.ac.cn.; Shandong Laboratory of Yantai Drug Discovery, Bohai Rim Advanced Research Institute for Drug Discovery, Yantai, 264117, Shandong, China. xxie@simm.ac.cn.

Source: Nature communications [Nat Commun] 2022 Nov 29; Vol. 13 (1), pp. 7345. Date of Electronic Publication: 2022 Nov 29.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

Authors: Zhang J; Center for Quantitative Biology and Peking-Tsinghua Center for Life Sciences, Academy for Advanced Interdisciplinary Studies, Peking University, Beijing 100871, China.; The MOE Key Laboratory of Cell Proliferation and Differentiation, School of Life Sciences, Peking University, Beijing 100871, China., Han X; Center for Quantitative Biology and Peking-Tsinghua Center for Life Sciences, Academy for Advanced Interdisciplinary Studies, Peking University, Beijing 100871, China.; The MOE Key Laboratory of Cell Proliferation and Differentiation, School of Life Sciences, Peking University, Beijing 100871, China., Ma L; Center for Quantitative Biology and Peking-Tsinghua Center for Life Sciences, Academy for Advanced Interdisciplinary Studies, Peking University, Beijing 100871, China.; The MOE Key Laboratory of Cell Proliferation and Differentiation, School of Life Sciences, Peking University, Beijing 100871, China., Xu S; Center for Quantitative Biology and Peking-Tsinghua Center for Life Sciences, Academy for Advanced Interdisciplinary Studies, Peking University, Beijing 100871, China.; The MOE Key Laboratory of Cell Proliferation and Differentiation, School of Life Sciences, Peking University, Beijing 100871, China., Lin Y; Center for Quantitative Biology and Peking-Tsinghua Center for Life Sciences, Academy for Advanced Interdisciplinary Studies, Peking University, Beijing 100871, China.; The MOE Key Laboratory of Cell Proliferation and Differentiation, School of Life Sciences, Peking University, Beijing 100871, China.

Source: Nucleic acids research [Nucleic Acids Res] 2023 Sep 22; Vol. 51 (17), pp. 9019-9038.

Publication Type: Journal Article

Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 0411011 Publication Model: Print Cited Medium: Internet ISSN: 1362-4962 (Electronic) Linking ISSN: 03051048 NLM ISO Abbreviation: Nucleic Acids Res Subsets: MEDLINE

Authors: Botta C; Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, University of Palermo, Palermo, Italy. cirino.botta@unipa.it.; Clinica Universidad de Navarra, Centro de Investigacion Medica Aplicada (CIMA), CCUN, Instituto de Investigacion Sanitaria de Navarra (IDISNA), CIBER-ONC numbers CB16/12/00369, CB16/12/00489, Pamplona, Spain. cirino.botta@unipa.it., Perez C; Clinica Universidad de Navarra, Centro de Investigacion Medica Aplicada (CIMA), CCUN, Instituto de Investigacion Sanitaria de Navarra (IDISNA), CIBER-ONC numbers CB16/12/00369, CB16/12/00489, Pamplona, Spain., Larrayoz M; Clinica Universidad de Navarra, Centro de Investigacion Medica Aplicada (CIMA), CCUN, Instituto de Investigacion Sanitaria de Navarra (IDISNA), CIBER-ONC numbers CB16/12/00369, CB16/12/00489, Pamplona, Spain., Puig N; Hospital Universitario de Salamanca, Instituto de Investigacion Biomedica de Salamanca (IBSAL), Centro de Investigación del Cancer (IBMCC-USAL, CSIC), CIBER-ONC number CB16/12/00233, Salamanca, Spain., Cedena MT; Hospital Universitario 12 de Octubre, CIBER-ONC number CB16/12/00369, Madrid, Spain., Termini R; Clinica Universidad de Navarra, Centro de Investigacion Medica Aplicada (CIMA), CCUN, Instituto de Investigacion Sanitaria de Navarra (IDISNA), CIBER-ONC numbers CB16/12/00369, CB16/12/00489, Pamplona, Spain., Goicoechea I; Clinica Universidad de Navarra, Centro de Investigacion Medica Aplicada (CIMA), CCUN, Instituto de Investigacion Sanitaria de Navarra (IDISNA), CIBER-ONC numbers CB16/12/00369, CB16/12/00489, Pamplona, Spain., Rodriguez S; Clinica Universidad de Navarra, Centro de Investigacion Medica Aplicada (CIMA), CCUN, Instituto de Investigacion Sanitaria de Navarra (IDISNA), CIBER-ONC numbers CB16/12/00369, CB16/12/00489, Pamplona, Spain., Zabaleta A; Clinica Universidad de Navarra, Centro de Investigacion Medica Aplicada (CIMA), CCUN, Instituto de Investigacion Sanitaria de Navarra (IDISNA), CIBER-ONC numbers CB16/12/00369, CB16/12/00489, Pamplona, Spain., Lopez A; Clinica Universidad de Navarra, Centro de Investigacion Medica Aplicada (CIMA), CCUN, Instituto de Investigacion Sanitaria de Navarra (IDISNA), CIBER-ONC numbers CB16/12/00369, CB16/12/00489, Pamplona, Spain., Sarvide S; Clinica Universidad de Navarra, Centro de Investigacion Medica Aplicada (CIMA), CCUN, Instituto de Investigacion Sanitaria de Navarra (IDISNA), CIBER-ONC numbers CB16/12/00369, CB16/12/00489, Pamplona, Spain., Blanco L; Clinica Universidad de Navarra, Centro de Investigacion Medica Aplicada (CIMA), CCUN, Instituto de Investigacion Sanitaria de Navarra (IDISNA), CIBER-ONC numbers CB16/12/00369, CB16/12/00489, Pamplona, Spain., Papetti DM; Department of Informatics, Systems and Communication, University of Milano-Bicocca, Milan, Italy., Nobile MS; Department of Environmental Sciences, Informatics and Statistics, Ca' Foscari University of Venice, Venice, Italy.; Bicocca Bioinformatics, Biostatistics and Bioimaging Centre-B4, Milan, Italy., Besozzi D; Department of Informatics, Systems and Communication, University of Milano-Bicocca, Milan, Italy.; Bicocca Bioinformatics, Biostatistics and Bioimaging Centre-B4, Milan, Italy., Gentile M; Department of Oncohematology, 'Annunziata' Hospital, Cosenza, Italy., Correale P; Medical Oncology Unit, Great Metropolitan Hospital 'Riuniti' of Reggio Calabria, Reggio Calabria, Italy., Siragusa S; Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, University of Palermo, Palermo, Italy., Oriol A; Institut Català d'Oncologia i Institut Josep Carreras, Badalona, Spain., González-Garcia ME; Servicios de Medicina Interna y Hematología, Hospital de Cabueñes, Gijón, Asturias, Spain., Sureda A; Institut Català d'Oncologia-Hospitalet, Instituto de Investigación Biomédica de Bellvitge (IDIBELL), Barcelona, Spain., de Arriba F; Hospital Morales Meseguer, IMIB-Arrixaca, Universidad de Murcia, Murcia, Spain., Rios Tamayo R; Hospital Universitario Puerta de Hierro, Majadahonda, Spain., Moraleda JM; Hospital Morales Meseguer, IMIB-Arrixaca, Universidad de Murcia, Murcia, Spain., Gironella M; Hospital Vall d'Hebron, Barcelona, Spain., Hernandez MT; Hospital Universitario de Canarias, Santa Cruz de Tenerife, Spain., Bargay J; Hospital Son Llatzer, Palma de Mallorca, Spain., Palomera L; Hospital Clínico Lozano Blesa, Zaragoza, Spain., Pérez-Montaña A; Hospital Son Espases, Palma de Mallorca, Spain., Goldschmidt H; Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany., Avet-Loiseau H; Unite de Genomique du Myelome, IUC-T Oncopole, Toulouse, France., Roccaro A; Department of Hematology, ASST Spedali Civili di Brescia, Brescia, BS, Italy., Orfao A; Cancer Research Center (IBMCC-CSIC/USAL-IBSAL), CIBER-ONC number CB16/12/00400, Salamanca, Spain.; Cytometry Service (NUCLEUS) and Department of Medicine, University of Salamanca, Salamanca, Spain., Martinez-Lopez J; Hospital Universitario 12 de Octubre, CIBER-ONC number CB16/12/00369, Madrid, Spain., Rosiñol L; Hospital Clínic IDIBAPS, Barcelona, Spain., Lahuerta JJ; Hospital Universitario 12 de Octubre, CIBER-ONC number CB16/12/00369, Madrid, Spain., Blade J; Hospital Clínic IDIBAPS, Barcelona, Spain., Mateos MV; Hospital Universitario de Salamanca, Instituto de Investigacion Biomedica de Salamanca (IBSAL), Centro de Investigación del Cancer (IBMCC-USAL, CSIC), CIBER-ONC number CB16/12/00233, Salamanca, Spain., San-Miguel JF; Clinica Universidad de Navarra, Centro de Investigacion Medica Aplicada (CIMA), CCUN, Instituto de Investigacion Sanitaria de Navarra (IDISNA), CIBER-ONC numbers CB16/12/00369, CB16/12/00489, Pamplona, Spain., Martinez Climent JA; Clinica Universidad de Navarra, Centro de Investigacion Medica Aplicada (CIMA), CCUN, Instituto de Investigacion Sanitaria de Navarra (IDISNA), CIBER-ONC numbers CB16/12/00369, CB16/12/00489, Pamplona, Spain., Paiva B; Clinica Universidad de Navarra, Centro de Investigacion Medica Aplicada (CIMA), CCUN, Instituto de Investigacion Sanitaria de Navarra (IDISNA), CIBER-ONC numbers CB16/12/00369, CB16/12/00489, Pamplona, Spain. bpaiva@unav.es.

Corporate Authors: Programa Para el Estudio de la Terapéutica en Hemopatías Malignas/Grupo Español de Mieloma (PETHEMA/GEM) cooperative group, iMMunocell study group

Source: Nature communications [Nat Commun] 2023 Sep 20; Vol. 14 (1), pp. 5825. Date of Electronic Publication: 2023 Sep 20.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

Authors: Brown DW; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA.; Cancer Prevention Fellowship Program, Division of Cancer Prevention, National Cancer Institute, Rockville, MD, USA., Cato LD; Division of Hematology/Oncology, Boston Children's Hospital and Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, 02115, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, 02142, USA., Zhao Y; MRC Epidemiology Unit, Wellcome-MRC Institute of Metabolic Science, University of Cambridge School of Clinical Medicine, Cambridge, CB2 0QQ, UK., Nandakumar SK; Division of Hematology/Oncology, Boston Children's Hospital and Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, 02115, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, 02142, USA.; Department of Cell Biology, Albert Einstein College of Medicine, Albert Einstein Cancer Center, Ruth L. and David S. Gottesman Institute for Stem Cell Research and Regenerative Medicine, Bronx, NY, 10461, USA., Bao EL; Division of Hematology/Oncology, Boston Children's Hospital and Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, 02115, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, 02142, USA., Gardner EJ; MRC Epidemiology Unit, Wellcome-MRC Institute of Metabolic Science, University of Cambridge School of Clinical Medicine, Cambridge, CB2 0QQ, UK., Hubbard AK; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA., DePaulis A; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA., Rehling T; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA., Song L; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA., Yu K; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA., Chanock SJ; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA., Perry JRB; MRC Epidemiology Unit, Wellcome-MRC Institute of Metabolic Science, University of Cambridge School of Clinical Medicine, Cambridge, CB2 0QQ, UK. john.perry@mrc-epid.cam.ac.uk.; Metabolic Research Laboratory, Wellcome-MRC Institute of Metabolic Science, University of Cambridge School of Clinical Medicine, Cambridge, CB2 0QQ, UK. john.perry@mrc-epid.cam.ac.uk., Sankaran VG; Division of Hematology/Oncology, Boston Children's Hospital and Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, 02115, USA. sankaran@broadinstitute.org.; Broad Institute of MIT and Harvard, Cambridge, MA, 02142, USA. sankaran@broadinstitute.org., Machiela MJ; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA. mitchell.machiela@nih.gov.

Source: Nature communications [Nat Commun] 2023 Sep 08; Vol. 14 (1), pp. 5536. Date of Electronic Publication: 2023 Sep 08.

Publication Type: Journal Article

Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

Authors: John L; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany.; Clinical Cooperation Unit Molecular Hematology/Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany., Poos AM; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany.; Clinical Cooperation Unit Molecular Hematology/Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany., Brobeil A; Department of Pathology, Heidelberg University Hospital, Heidelberg, Germany., Schinke C; Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, AR, USA., Huhn S; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany., Prokoph N; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany.; Clinical Cooperation Unit Molecular Hematology/Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany., Lutz R; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany.; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), Heidelberg, Germany.; Division of Stem Cells and Cancer, German Cancer Research Center (DKFZ) and DKFZ-ZMBH Alliance, Heidelberg, Germany., Wagner B; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany., Zangari M; Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, AR, USA., Tirier SM; Division of Chromatin Networks, German Cancer Research Center (DKFZ) and BioQuant, Heidelberg, Germany., Mallm JP; Single Cell Open Lab, German Cancer Research Center (DKFZ) and BioQuant, Heidelberg, Germany., Schumacher S; Division of Chromatin Networks, German Cancer Research Center (DKFZ) and BioQuant, Heidelberg, Germany., Vonficht D; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), Heidelberg, Germany.; Division of Stem Cells and Cancer, German Cancer Research Center (DKFZ) and DKFZ-ZMBH Alliance, Heidelberg, Germany., Solé-Boldo L; Institute of Health (BIH) at Charité-Universitätsmedizin Berlin, Berlin, Germany.; Berlin Institute for Medical Systems Biology, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.; Department of Hematology, Oncology and Tumor Immunology, Charité University Medicine, Berlin, Germany., Quick S; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany., Steiger S; Division of Chromatin Networks, German Cancer Research Center (DKFZ) and BioQuant, Heidelberg, Germany., Przybilla MJ; Division Computational Genomics and Systems Genetics, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Wellcome Sanger Institute, Wellcome Trust Genome Campus, Cambridge, UK., Bauer K; Single Cell Open Lab, German Cancer Research Center (DKFZ) and BioQuant, Heidelberg, Germany., Baumann A; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany.; Clinical Cooperation Unit Molecular Hematology/Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany., Hemmer S; Department of Orthopedic Surgery, Heidelberg University Hospital, Heidelberg, Germany., Rehnitz C; Department of Radiology, Heidelberg University Hospital, Heidelberg, Germany., Lückerath C; Department of Radiology, Heidelberg University Hospital, Heidelberg, Germany., Sachpekidis C; Department of Nuclear Medicine, University Hospital Heidelberg, Heidelberg, Germany.; Clinical Cooperation Unit Nuclear Medicine, German Cancer Research Center (DKFZ), Heidelberg, Germany., Mechtersheimer G; Department of Pathology, Heidelberg University Hospital, Heidelberg, Germany., Haberkorn U; Department of Nuclear Medicine, University Hospital Heidelberg, Heidelberg, Germany., Dimitrakopoulou-Strauss A; Department of Nuclear Medicine, University Hospital Heidelberg, Heidelberg, Germany.; Clinical Cooperation Unit Nuclear Medicine, German Cancer Research Center (DKFZ), Heidelberg, Germany., Reichert P; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany., Barlogie B; Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, AR, USA., Müller-Tidow C; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany.; National Center for Tumor Diseases (NCT), Heidelberg, Germany., Goldschmidt H; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany.; National Center for Tumor Diseases (NCT), Heidelberg, Germany., Hillengass J; Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA., Rasche L; Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, AR, USA.; Department of Internal Medicine 2, University Hospital of Würzburg, Würzburg, Germany.; Mildred Scheel Early Career Center (MSNZ), University Hospital of Würzburg, Würzburg, Germany., Haas SF; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), Heidelberg, Germany.; Institute of Health (BIH) at Charité-Universitätsmedizin Berlin, Berlin, Germany.; Berlin Institute for Medical Systems Biology, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.; Department of Hematology, Oncology and Tumor Immunology, Charité University Medicine, Berlin, Germany., van Rhee F; Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, AR, USA., Rippe K; Division of Chromatin Networks, German Cancer Research Center (DKFZ) and BioQuant, Heidelberg, Germany., Raab MS; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany.; Clinical Cooperation Unit Molecular Hematology/Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany., Sauer S; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany., Weinhold N; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany. niels.weinhold@med.uni-heidelberg.de.; Clinical Cooperation Unit Molecular Hematology/Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany. niels.weinhold@med.uni-heidelberg.de.; Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, AR, USA. niels.weinhold@med.uni-heidelberg.de.

Source: Nature communications [Nat Commun] 2023 Aug 17; Vol. 14 (1), pp. 5011. Date of Electronic Publication: 2023 Aug 17.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

Authors: Hasan AMM; University College London Cancer Institute, London, UK., Cremaschi P; University College London Cancer Institute, London, UK., Wetterskog D; University College London Cancer Institute, London, UK., Jayaram A; University College London Cancer Institute, London, UK.; University College London Hospitals, London, UK., Wong SQ; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; The Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC, Australia., Williams S; The Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC, Australia., Pasam A; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Trigos A; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Trujillo B; University College London Cancer Institute, London, UK.; University College London Hospitals, London, UK., Grist E; University College London Cancer Institute, London, UK., Friedrich S; University College London Cancer Institute, London, UK., Vainauskas O; University College London Cancer Institute, London, UK., Parry M; University College London Cancer Institute, London, UK., Ismail M; University College London Cancer Institute, London, UK., Devlies W; University College London Cancer Institute, London, UK., Wingate A; University College London Cancer Institute, London, UK., Linch M; University College London Cancer Institute, London, UK.; University College London Hospitals, London, UK., Naceur-Lombardelli C; University College London Cancer Institute, London, UK., Swanton C; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Department of Oncology, University College London Hospitals, London, UK., Jamal-Hanjani M; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Department of Oncology, University College London Hospitals, London, UK.; Cancer Metastasis Laboratory, University College London Cancer Institute, London, UK., Lise S; University College London Cancer Institute, London, UK., Sandhu S; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Attard G; University College London Cancer Institute, London, UK. g.attard@ucl.ac.uk.; University College London Hospitals, London, UK. g.attard@ucl.ac.uk.

Corporate Authors: PEACE consortium

Source: Nature communications [Nat Commun] 2023 Aug 10; Vol. 14 (1), pp. 4823. Date of Electronic Publication: 2023 Aug 10.

Publication Type: Journal Article

Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

Authors: Xie J; The Interdisciplinary Program in Biostatistics, The Ohio State University, Columbus, Ohio, United States of America., Jeon H; Department of Biomedical Informatics, The Ohio State University, Columbus, Ohio, United States of America.; Pelotonia Institute for Immuno-Oncology, The James Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio, United States of America., Xin G; Pelotonia Institute for Immuno-Oncology, The James Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio, United States of America.; Department of Microbial Infection and Immunity, The Ohio State University, Columbus, Ohio, United States of America., Ma Q; Department of Biomedical Informatics, The Ohio State University, Columbus, Ohio, United States of America.; Pelotonia Institute for Immuno-Oncology, The James Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio, United States of America., Chung D; Department of Biomedical Informatics, The Ohio State University, Columbus, Ohio, United States of America.; Pelotonia Institute for Immuno-Oncology, The James Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio, United States of America.

Source: PLoS computational biology [PLoS Comput Biol] 2023 Jul 10; Vol. 19 (7), pp. e1011300. Date of Electronic Publication: 2023 Jul 10 (Print Publication: 2023).

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101238922 Publication Model: eCollection Cited Medium: Internet ISSN: 1553-7358 (Electronic) Linking ISSN: 1553734X NLM ISO Abbreviation: PLoS Comput Biol Subsets: MEDLINE

Transliterated Title: Escherichia coli İzolatlarında O25b-ST131 Klonu Sıklığı ile Karbapenem ve Fosfomisin Direnç Genlerinin Varlığının Araştırılması: Escherichia coli O25b-ST131 İzolatlarında Türkiye’den İlk fosA3 Tespiti.

Authors: Tanrıverdi Çaycı Y; Ondokuz Mayıs University Faculty of Medicine, Department of Medical Microbiology, Samsun, Türkiye., Hacıeminoğlu Ülker K; Ondokuz Mayıs University Faculty of Medicine, Department of Medical Microbiology, Samsun, Türkiye., Karacan Temür G; Ondokuz Mayıs University Faculty of Medicine, Department of Medical Microbiology, Samsun, Türkiye., Güney DB; Ondokuz Mayıs University Faculty of Medicine, Samsun, Türkiye., Ertokatlı M; Ondokuz Mayıs University Faculty of Medicine, Samsun, Türkiye., Birinci A; Ondokuz Mayıs University Faculty of Medicine, Department of Medical Microbiology, Samsun, Türkiye.

Source: Mikrobiyoloji bulteni [Mikrobiyol Bul] 2023 Jul; Vol. 57 (3), pp. 454-462.

Publication Type: English Abstract; Journal Article

Journal Info: Publisher: Ankara Mikrobiyoloji Dernegi Country of Publication: Turkey NLM ID: 7503830 Publication Model: Print Cited Medium: Print ISSN: 0374-9096 (Print) Linking ISSN: 03749096 NLM ISO Abbreviation: Mikrobiyol Bul Subsets: MEDLINE

Authors: Al Bakir M; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Huebner A; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Martínez-Ruiz C; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Grigoriadis K; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Watkins TBK; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Pich O; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Moore DA; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Department of Cellular Pathology, University College London Hospitals, London, UK., Veeriah S; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Ward S; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Advanced Sequencing Facility, The Francis Crick Institute, London, UK., Laycock J; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Johnson D; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Rowan A; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Razaq M; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Akther M; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Naceur-Lombardelli C; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Prymas P; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Toncheva A; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Hessey S; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Metastasis Laboratory, University College London Cancer Institute, London, UK.; Computational Cancer Genomics Research Group, University College London Cancer Institute, London, UK., Dietzen M; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Colliver E; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Frankell AM; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Bunkum A; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Metastasis Laboratory, University College London Cancer Institute, London, UK.; Computational Cancer Genomics Research Group, University College London Cancer Institute, London, UK., Lim EL; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Karasaki T; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Metastasis Laboratory, University College London Cancer Institute, London, UK., Abbosh C; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Hiley CT; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Hill MS; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Cook DE; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Wilson GA; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Salgado R; Department of Pathology, ZAS Hospitals, Antwerp, Belgium.; Division of Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Nye E; Experimental Histopathology, The Francis Crick Institute, London, UK., Stone RK; Experimental Histopathology, The Francis Crick Institute, London, UK., Fennell DA; University of Leicester, Leicester, UK.; University Hospitals of Leicester NHS Trust, Leicester, UK., Price G; Department of Medical Oncology, Aberdeen Royal Infirmary NHS Grampian, Aberdeen, UK.; University of Aberdeen, Aberdeen, UK., Kerr KM; University of Aberdeen, Aberdeen, UK.; Department of Pathology, Aberdeen Royal Infirmary NHS Grampian, Aberdeen, UK., Naidu B; Birmingham Acute Care Research Group, Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UK., Middleton G; University Hospital Birmingham NHS Foundation Trust, Birmingham, UK.; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK., Summers Y; Division of Cancer Sciences, The University of Manchester and The Christie NHS Foundation Trust, Manchester, UK., Lindsay CR; Division of Cancer Sciences, The University of Manchester and The Christie NHS Foundation Trust, Manchester, UK., Blackhall FH; Division of Cancer Sciences, The University of Manchester and The Christie NHS Foundation Trust, Manchester, UK., Cave J; Department of Oncology, University Hospital Southampton NHS Foundation Trust, Southampton, UK., Blyth KG; School of Cancer Sciences, University of Glasgow, Glasgow, UK.; Cancer Research UK Beatson Institute, Glasgow, UK.; Queen Elizabeth University Hospital, Glasgow, UK., Nair A; Department of Radiology, University College London Hospitals, London, UK.; UCL Respiratory, Department of Medicine, University College London, London, UK., Ahmed A; Department of Radiology, University College London Hospitals, London, UK., Taylor MN; Department of Radiology, University College London Hospitals, London, UK., Procter AJ; Department of Radiology, University College London Hospitals, London, UK., Falzon M; Department of Cellular Pathology, University College London Hospitals, London, UK., Lawrence D; Department of Thoracic Surgery, University College London Hospital NHS Trust, London, UK., Navani N; Lungs for Living Research Centre, UCL Respiratory, University College London, London, UK.; Department of Thoracic Medicine, University College London Hospitals, London, UK., Thakrar RM; Lungs for Living Research Centre, UCL Respiratory, University College London, London, UK.; Department of Thoracic Medicine, University College London Hospitals, London, UK., Janes SM; Lungs for Living Research Centre, UCL Respiratory, University College London, London, UK., Papadatos-Pastos D; Department of Oncology, University College London Hospitals, London, UK., Forster MD; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Department of Oncology, University College London Hospitals, London, UK., Lee SM; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Department of Oncology, University College London Hospitals, London, UK., Ahmad T; Department of Oncology, University College London Hospitals, London, UK., Quezada SA; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Immune Regulation and Tumour Immunotherapy Group, Cancer Immunology Unit, Research Department of Haematology, University College London Cancer Institute, London, UK., Peggs KS; Department of Haematology, University College London Hospitals, London, UK.; Cancer Immunology Unit, Research Department of Haematology, University College London Cancer Institute, London, UK., Van Loo P; Cancer Genomics Laboratory, The Francis Crick Institute, London, UK.; Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Dive C; Cancer Research UK Manchester Institute Cancer Biomarker Centre, University of Manchester, Manchester, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University of Manchester, Manchester, UK., Hackshaw A; Cancer Research UK & UCL Cancer Trials Centre, London, UK., Birkbak NJ; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.; Bioinformatics Research Centre, Aarhus University, Aarhus, Denmark., Zaccaria S; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Computational Cancer Genomics Research Group, University College London Cancer Institute, London, UK., Jamal-Hanjani M; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK. m.jamal-hanjani@ucl.ac.uk.; Cancer Metastasis Laboratory, University College London Cancer Institute, London, UK. m.jamal-hanjani@ucl.ac.uk.; Department of Oncology, University College London Hospitals, London, UK. m.jamal-hanjani@ucl.ac.uk., McGranahan N; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK. nicholas.mcgranahan.10@ucl.ac.uk.; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK. nicholas.mcgranahan.10@ucl.ac.uk., Swanton C; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK. Charles.Swanton@crick.ac.uk.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK. Charles.Swanton@crick.ac.uk.; Department of Oncology, University College London Hospitals, London, UK. Charles.Swanton@crick.ac.uk.

Corporate Authors: TRACERx Consortium

Source: Nature [Nature] 2023 Apr; Vol. 616 (7957), pp. 534-542. Date of Electronic Publication: 2023 Apr 12.

Publication Type: Journal Article

Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 0410462 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-4687 (Electronic) Linking ISSN: 00280836 NLM ISO Abbreviation: Nature Subsets: MEDLINE

MeSH Terms: Carcinoma, Non-Small-Cell Lung*/pathology , Clonal Evolution* , Clone Cells*/pathology , Evolution, Molecular* , Lung Neoplasms*/pathology , Neoplasm Metastasis*/diagnosis , Neoplasm Metastasis*/pathology, Humans ; Cohort Studies ; Disease Progression ; Neoplasm Recurrence, Local

Authors: Ormsby MJ; School of Infection and Immunity, College of Medical, Veterinary & Life Sciences, University of Glasgow, Scotland, United Kingdom., Vaz F; School of Infection and Immunity, College of Medical, Veterinary & Life Sciences, University of Glasgow, Scotland, United Kingdom., Kirk JA; Molecular Microbiology, School of Biosciences, University of Sheffield, England, United Kingdom., Barwinska-Sendra A; Biosciences Institute, Faculty of Medical Sciences, Newcastle University, England, United Kingdom., Hallam JC; School of Infection and Immunity, College of Medical, Veterinary & Life Sciences, University of Glasgow, Scotland, United Kingdom., Lanzoni-Mangutchi P; Biosciences Institute, Faculty of Medical Sciences, Newcastle University, England, United Kingdom., Cole J; School of Infection and Immunity, College of Medical, Veterinary & Life Sciences, University of Glasgow, Scotland, United Kingdom., Chaudhuri RR; Molecular Microbiology, School of Biosciences, University of Sheffield, England, United Kingdom., Salgado PS; Biosciences Institute, Faculty of Medical Sciences, Newcastle University, England, United Kingdom., Fagan RP; Molecular Microbiology, School of Biosciences, University of Sheffield, England, United Kingdom., Douce GR; School of Infection and Immunity, College of Medical, Veterinary & Life Sciences, University of Glasgow, Scotland, United Kingdom.

Source: PLoS pathogens [PLoS Pathog] 2023 Jun 29; Vol. 19 (6), pp. e1011015. Date of Electronic Publication: 2023 Jun 29 (Print Publication: 2023).

Publication Type: Journal Article

Journal Info: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101238921 Publication Model: eCollection Cited Medium: Internet ISSN: 1553-7374 (Electronic) Linking ISSN: 15537366 NLM ISO Abbreviation: PLoS Pathog Subsets: MEDLINE

Authors: Wojtowicz EE; Earlham Institute, Norwich Research Park, Norwich, UK. edyta.wojtowicz@earlham.ac.uk.; Norwich Medical School, University of East Anglia, Norwich, UK. edyta.wojtowicz@earlham.ac.uk.; Department of Cell and Molecular Biology, Karolinska Institutet, Stockholm, Sweden. edyta.wojtowicz@earlham.ac.uk.; Department of Medicine, Huddinge, Center for Hematology and Regenerative Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden. edyta.wojtowicz@earlham.ac.uk., Mistry JJ; Earlham Institute, Norwich Research Park, Norwich, UK.; Norwich Medical School, University of East Anglia, Norwich, UK., Uzun V; Earlham Institute, Norwich Research Park, Norwich, UK., Hellmich C; Norwich Medical School, University of East Anglia, Norwich, UK.; Norfolk and Norwich University Hospital, Norwich, UK., Scoones A; Earlham Institute, Norwich Research Park, Norwich, UK., Chin DW; Department of Medicine, Huddinge, Center for Hematology and Regenerative Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden., Kettyle LM; Department of Cell and Molecular Biology, Karolinska Institutet, Stockholm, Sweden.; Department of Medicine, Huddinge, Center for Hematology and Regenerative Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden., Grasso F; Department of Medicine, Huddinge, Center for Hematology and Regenerative Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden., Lord AM; Department of Cell and Molecular Biology, Karolinska Institutet, Stockholm, Sweden.; Department of Medicine, Huddinge, Center for Hematology and Regenerative Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden., Wright DJ; Earlham Institute, Norwich Research Park, Norwich, UK., Etherington GJ; Earlham Institute, Norwich Research Park, Norwich, UK., Woll PS; Department of Medicine, Huddinge, Center for Hematology and Regenerative Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden., Belderbos ME; Princess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands., Bowles KM; Norwich Medical School, University of East Anglia, Norwich, UK.; Norfolk and Norwich University Hospital, Norwich, UK., Nerlov C; MRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK., Haerty W; Earlham Institute, Norwich Research Park, Norwich, UK.; School of Biological Sciences, University of East Anglia, Norwich, UK., Bystrykh LV; European Research Institute for the Biology of Ageing (ERIBA), University Medical Center of Groningen (UMCG), University of Groningen, Groningen, The Netherlands., Jacobsen SEW; Department of Cell and Molecular Biology, Karolinska Institutet, Stockholm, Sweden. sten.eirik.jacobsen@ki.se.; Department of Medicine, Huddinge, Center for Hematology and Regenerative Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden. sten.eirik.jacobsen@ki.se.; MRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK. sten.eirik.jacobsen@ki.se., Rushworth SA; Norwich Medical School, University of East Anglia, Norwich, UK. s.rushworth@uea.ac.uk., Macaulay IC; Earlham Institute, Norwich Research Park, Norwich, UK. iain.macaulay@earlham.ac.uk.; Norwich Medical School, University of East Anglia, Norwich, UK. iain.macaulay@earlham.ac.uk.

Source: Genome biology [Genome Biol] 2023 Jun 27; Vol. 24 (1), pp. 152. Date of Electronic Publication: 2023 Jun 27.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 100960660 Publication Model: Electronic Cited Medium: Internet ISSN: 1474-760X (Electronic) Linking ISSN: 14747596 NLM ISO Abbreviation: Genome Biol Subsets: MEDLINE

Authors: Rezenman S; Department of Biomolecular Sciences, Weizmann Institute of Science Rehovot, Rehovot, Israel., Knafo M; Department of Biomolecular Sciences, Weizmann Institute of Science Rehovot, Rehovot, Israel., Tsigalnitski I; Department of Biomolecular Sciences, Weizmann Institute of Science Rehovot, Rehovot, Israel., Barad S; Department of Biomolecular Sciences, Weizmann Institute of Science Rehovot, Rehovot, Israel., Jona G; Life Sciences Core Facilities, Weizmann Institute of Science Rehovot, Rehovot, Israel., Levi D; Life Sciences Core Facilities, Weizmann Institute of Science Rehovot, Rehovot, Israel., Dym O; The Dana and Yossie Hollander Center for Structural Proteomics, Weizmann Institute of Science Rehovot, Rehovot, Israel., Reich Z; Department of Biomolecular Sciences, Weizmann Institute of Science Rehovot, Rehovot, Israel., Kapon R; Department of Biomolecular Sciences, Weizmann Institute of Science Rehovot, Rehovot, Israel.

Source: PloS one [PLoS One] 2023 Jun 07; Vol. 18 (6), pp. e0286696. Date of Electronic Publication: 2023 Jun 07 (Print Publication: 2023).

Publication Type: Journal Article

Journal Info: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE

Authors: Schmidt J; Ludwig Institute for Cancer Research, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland.; Center of Experimental Therapeutics, Department of Oncology, Lausanne University Hospital (CHUV), Lausanne, Switzerland., Chiffelle J; Ludwig Institute for Cancer Research, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland., Perez MAS; Ludwig Institute for Cancer Research, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Swiss Institute of Bioinformatics (SIB), Lausanne, Switzerland., Magnin M; Ludwig Institute for Cancer Research, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland., Bobisse S; Ludwig Institute for Cancer Research, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland., Arnaud M; Ludwig Institute for Cancer Research, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland., Genolet R; Ludwig Institute for Cancer Research, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland., Cesbron J; Ludwig Institute for Cancer Research, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland., Barras D; Ludwig Institute for Cancer Research, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland., Navarro Rodrigo B; Ludwig Institute for Cancer Research, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland., Benedetti F; Ludwig Institute for Cancer Research, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland., Michel A; Ludwig Institute for Cancer Research, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland., Queiroz L; Ludwig Institute for Cancer Research, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland., Baumgaertner P; Ludwig Institute for Cancer Research, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center of Experimental Therapeutics, Department of Oncology, Lausanne University Hospital (CHUV), Lausanne, Switzerland., Guillaume P; Ludwig Institute for Cancer Research, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland.; Center of Experimental Therapeutics, Department of Oncology, Lausanne University Hospital (CHUV), Lausanne, Switzerland., Hebeisen M; Ludwig Institute for Cancer Research, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland., Michielin O; Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland., Nguyen-Ngoc T; Ludwig Institute for Cancer Research, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland., Huber F; Ludwig Institute for Cancer Research, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland., Irving M; Ludwig Institute for Cancer Research, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland., Tissot-Renaud S; Ludwig Institute for Cancer Research, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center of Experimental Therapeutics, Department of Oncology, Lausanne University Hospital (CHUV), Lausanne, Switzerland., Stevenson BJ; Ludwig Institute for Cancer Research, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland.; Swiss Institute of Bioinformatics (SIB), Lausanne, Switzerland., Rusakiewicz S; Ludwig Institute for Cancer Research, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center of Experimental Therapeutics, Department of Oncology, Lausanne University Hospital (CHUV), Lausanne, Switzerland., Dangaj Laniti D; Ludwig Institute for Cancer Research, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland., Bassani-Sternberg M; Ludwig Institute for Cancer Research, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland., Rufer N; Ludwig Institute for Cancer Research, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland., Gfeller D; Ludwig Institute for Cancer Research, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Swiss Institute of Bioinformatics (SIB), Lausanne, Switzerland., Kandalaft LE; Ludwig Institute for Cancer Research, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland.; Center of Experimental Therapeutics, Department of Oncology, Lausanne University Hospital (CHUV), Lausanne, Switzerland., Speiser DE; Ludwig Institute for Cancer Research, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland., Zoete V; Ludwig Institute for Cancer Research, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Swiss Institute of Bioinformatics (SIB), Lausanne, Switzerland., Coukos G; Ludwig Institute for Cancer Research, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.; Center for Cell Therapy, Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland.; Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland., Harari A; Ludwig Institute for Cancer Research, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland. Alexandre.Harari@chuv.ch.; Center for Cell Therapy, Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland. Alexandre.Harari@chuv.ch.

Source: Nature communications [Nat Commun] 2023 Jun 06; Vol. 14 (1), pp. 3188. Date of Electronic Publication: 2023 Jun 06.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

Authors: Del Core L; Bernoulli Institute for Mathematics, Computer Science and Artificial Intelligence, University of Groningen, Groningen, The Netherlands. luca.delcore@nottingham.ac.uk.; School of Mathematical Sciences, University of Nottingham, Nottingham, UK. luca.delcore@nottingham.ac.uk., Pellin D; Harvard Medical School, Harvard University, Boston, MA, USA. danilo_pellin@dfci.harvard.edu., Wit EC; Bernoulli Institute for Mathematics, Computer Science and Artificial Intelligence, University of Groningen, Groningen, The Netherlands. ernst.jan.camiel.wit@usi.ch.; Institute of Computing, Università della Svizzera italiana, Lugano, Switzerland. ernst.jan.camiel.wit@usi.ch., Grzegorczyk MA; Bernoulli Institute for Mathematics, Computer Science and Artificial Intelligence, University of Groningen, Groningen, The Netherlands. m.a.grzegorczyk@rug.nl.

Source: BMC bioinformatics [BMC Bioinformatics] 2023 Jun 02; Vol. 24 (1), pp. 228. Date of Electronic Publication: 2023 Jun 02.

Publication Type: Journal Article

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 100965194 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2105 (Electronic) Linking ISSN: 14712105 NLM ISO Abbreviation: BMC Bioinformatics Subsets: MEDLINE

Authors: Alkemade JA; Department of Crop Sciences, Research Institute of Organic Agriculture (FiBL), Frick, Switzerland.; Department of Agricultural and Food Sciences (DISTAL), University of Bologna, Bologna, Italy., Baroncelli R; Department of Agricultural and Food Sciences (DISTAL), University of Bologna, Bologna, Italy.; Centre for Studies on Bioinspired Agro-Enviromental Technology, Università di Napoli Federico II, Portici, 80055, Italy., Messmer MM; Department of Crop Sciences, Research Institute of Organic Agriculture (FiBL), Frick, Switzerland., Hohmann P; Department of Crop Sciences, Research Institute of Organic Agriculture (FiBL), Frick, Switzerland.; Bonaplanta, BioCrops Innovations SL, Manresa, Spain.

Source: Molecular plant pathology [Mol Plant Pathol] 2023 Jun; Vol. 24 (6), pp. 616-627. Date of Electronic Publication: 2023 Apr 20.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Blackwell Science in collaboration with the British Society of Plant Pathology Country of Publication: England NLM ID: 100954969 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1364-3703 (Electronic) Linking ISSN: 13643703 NLM ISO Abbreviation: Mol Plant Pathol Subsets: MEDLINE

Authors: Carneiro CS; Department of Biology, University of New Brunswick, Fredericton, NB, E3B 5A3, Canada., Hapeman JD; Department of Biology, University of New Brunswick, Fredericton, NB, E3B 5A3, Canada., Nedelcu AM; Department of Biology, University of New Brunswick, Fredericton, NB, E3B 5A3, Canada. anedelcu@unb.ca.

Source: BMC ecology and evolution [BMC Ecol Evol] 2023 May 24; Vol. 23 (1), pp. 20. Date of Electronic Publication: 2023 May 24.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101775613 Publication Model: Electronic Cited Medium: Internet ISSN: 2730-7182 (Electronic) Linking ISSN: 27307182 NLM ISO Abbreviation: BMC Ecol Evol Subsets: MEDLINE

Authors: Firoozeh F; Department of Microbiology, School of Medicine, Alborz University of Medical Sciences, Karaj, Iran.; Evidence-based Phytotherapy and Complementary Medicine Research Center, Alborz University of Medical Sciences, Karaj, Iran., Nikibakhsh M; Department of Microbiology, School of Medicine, Alborz University of Medical Sciences, Karaj, Iran., Badmasti F; Department of Bacteriology, Pasteur Institute of Iran, Tehran, Iran. fbadmasti2008@gmail.com., Zibaei M; Department of Parasitology and Mycology, School of Medicine, Alborz University of Medical Sciences, Karaj, Iran., Nikbin VS; Department of Bacteriology, Pasteur Institute of Iran, Tehran, Iran.

Source: Annals of clinical microbiology and antimicrobials [Ann Clin Microbiol Antimicrob] 2023 May 06; Vol. 22 (1), pp. 34. Date of Electronic Publication: 2023 May 06.

Publication Type: Journal Article

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101152152 Publication Model: Electronic Cited Medium: Internet ISSN: 1476-0711 (Electronic) Linking ISSN: 14760711 NLM ISO Abbreviation: Ann Clin Microbiol Antimicrob Subsets: MEDLINE

Authors: Frank E; INSERM U861, I-Stem, AFM, Institute for Stem cell Therapy and Exploration of Monogenic Diseases, 91100, Corbeil-Essonnes, France.; U861, I-Stem, AFM, Université Paris-Saclay, Université d'Evry, 91100, Corbeil-Essonnes, France., Cailleret M; INSERM U861, I-Stem, AFM, Institute for Stem cell Therapy and Exploration of Monogenic Diseases, 91100, Corbeil-Essonnes, France.; U861, I-Stem, AFM, Université Paris-Saclay, Université d'Evry, 91100, Corbeil-Essonnes, France., Nelep C; ALS Automated Lab Solutions GmbH, 07745, Jena, Germany., Fragner P; INSERM U861, I-Stem, AFM, Institute for Stem cell Therapy and Exploration of Monogenic Diseases, 91100, Corbeil-Essonnes, France.; U861, I-Stem, AFM, Université Paris-Saclay, Université d'Evry, 91100, Corbeil-Essonnes, France.; CECS, Centre d'étude des cellules souches, 91100, Corbeil-Essonnes, France., Polentes J; INSERM U861, I-Stem, AFM, Institute for Stem cell Therapy and Exploration of Monogenic Diseases, 91100, Corbeil-Essonnes, France.; U861, I-Stem, AFM, Université Paris-Saclay, Université d'Evry, 91100, Corbeil-Essonnes, France.; CECS, Centre d'étude des cellules souches, 91100, Corbeil-Essonnes, France., Herardot E; INSERM U861, I-Stem, AFM, Institute for Stem cell Therapy and Exploration of Monogenic Diseases, 91100, Corbeil-Essonnes, France.; U861, I-Stem, AFM, Université Paris-Saclay, Université d'Evry, 91100, Corbeil-Essonnes, France., El Kassar L; INSERM U861, I-Stem, AFM, Institute for Stem cell Therapy and Exploration of Monogenic Diseases, 91100, Corbeil-Essonnes, France.; U861, I-Stem, AFM, Université Paris-Saclay, Université d'Evry, 91100, Corbeil-Essonnes, France.; CECS, Centre d'étude des cellules souches, 91100, Corbeil-Essonnes, France., Giraud-Triboult K; INSERM U861, I-Stem, AFM, Institute for Stem cell Therapy and Exploration of Monogenic Diseases, 91100, Corbeil-Essonnes, France.; U861, I-Stem, AFM, Université Paris-Saclay, Université d'Evry, 91100, Corbeil-Essonnes, France.; CECS, Centre d'étude des cellules souches, 91100, Corbeil-Essonnes, France., Monville C; INSERM U861, I-Stem, AFM, Institute for Stem cell Therapy and Exploration of Monogenic Diseases, 91100, Corbeil-Essonnes, France. cmonville@istem.fr.; U861, I-Stem, AFM, Université Paris-Saclay, Université d'Evry, 91100, Corbeil-Essonnes, France. cmonville@istem.fr., Ben M'Barek K; INSERM U861, I-Stem, AFM, Institute for Stem cell Therapy and Exploration of Monogenic Diseases, 91100, Corbeil-Essonnes, France. kbenmbarek@istem.fr.; U861, I-Stem, AFM, Université Paris-Saclay, Université d'Evry, 91100, Corbeil-Essonnes, France. kbenmbarek@istem.fr.; CECS, Centre d'étude des cellules souches, 91100, Corbeil-Essonnes, France. kbenmbarek@istem.fr.

Source: Stem cell research & therapy [Stem Cell Res Ther] 2023 Apr 27; Vol. 14 (1), pp. 110. Date of Electronic Publication: 2023 Apr 27.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101527581 Publication Model: Electronic Cited Medium: Internet ISSN: 1757-6512 (Electronic) Linking ISSN: 17576512 NLM ISO Abbreviation: Stem Cell Res Ther Subsets: MEDLINE